“[...] these inexpensive, widely available tests with rapid turnaround times and relatively short half-lives (CEA, CA-125, and CA19-9) are perfectly situated to ...

A new research paper was published in Oncotarget's Volume 15 on June 13, 2024, entitled, "Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management ...

A novel intelligent biosensing platform consisting of quantum dots luminescence and biochip with machine vision algorithm is proposed for point-of-care carcinoembryonic antigen (CEA) protein ...

Tumor marker blood tests may help inform various aspects of cancer care, including diagnosis, staging, treatment planning, and outlook. However, they’re often not the only diagnostic tests used. If ...

Lee Biosolutions Inc. has expanded its line of biomarkers to include products used to track epithelial ovarian cancer, breast cancer and liver cancer. Lee Biosolutions Inc. has expanded its line of ...

Comparative effectiveness assessment of a lung cancer multidisciplinary practice to improve patient care. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not ...

However, tumor marker tests aren’t the only tools they’ll use in cancer care. Other testing techniques will help provide a more comprehensive look at your type of cancer. Regular cells may produce ...